Skip to main content
Premium Trial:

Request an Annual Quote

UMN Pharma to Manufacture, Sell Protein Sciences' Flu Vaccine in Japan

NEW YORK (GenomeWeb News) – Protein Sciences has licensed its FluBiok recombinant influenza vaccine to Japanese biotech UMN Pharma to make and sell the product in that market.
 
Terms of the deal call for PSC to transfer technology to UMN, which will register, manufacture, market, and sell the vaccine in Japan for annual and pandemic use.
 
One the test is registered with Japanese regulators, UMN will buy commercial quantities of FluBiok from PSC until a commercial manufacturing facility is available in the country.
 
The license terms include a multimillion-dollar upfront payment and double-digit royalties, PSC said.
 
FluBiok has received "accelerated approval" status from the US Food and Drug Administration and PSC said it expects to file a Biologics License Application with the agency in early 2007.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.